Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a well established pharmacological class of drug for the management of diabetes and sometimes as a treatment for patients who are overweight or obese without diabetes. This evidence concerns the gene GLP1R and diabetes mellitus.